A Phase 1, Open-label, Two-period, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Single-dose Pharmacokinetics Of Pf-06648671 In Healthy Adults
Phase of Trial: Phase I
Latest Information Update: 22 Dec 2016
At a glance
- Drugs PF 6648671 (Primary) ; Itraconazole
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Pfizer
- 19 Dec 2016 Status changed from recruiting to completed.
- 23 Sep 2016 Status changed from not yet recruiting to recruiting.
- 16 Sep 2016 New trial record